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The Importance of Cationic Amino Acid Transporter Expression
in Human Skin
Oliver Schnorr, ChristophV. Suschek, and Victoria Kolb-Bachofen
Research Group Immunobiology, Biomedical Research Center, University of Dˇsseldorf, Dˇsseldorf, Germany
Inducible nitric oxide synthase and arginase activities
are acknowledged as important players in human skin
epidermal function. For proper enzyme function the
substrate availability of L-arginine for both enzymes
and thus its transport across the cell membrane via the
yþ-system (also named cationic amino acid transpor-
ters) is critical. Here, we examine the expression of ca-
tionic amino acid transporters and their functional role
in modulating inducible nitric oxide synthase and argi-
nase activities in human skin and primary keratino-
cytes, ¢broblasts and endothelial cells as well as their
impact on keratinocyte proliferation. Skin biopsies
were found to express constitutively both cationic
amino acid transporter-1 and cationic amino acid trans-
porter-2 mRNA, an expression pattern known to occur
in hepatocytes and muscle cells only. To determine the
cellular components expressing cationic amino acid
transporter, we analyzed the expression patterns in the
di¡erent human skin cell types in vitro, i.e., in ¢bro-
blasts, dermal endothelial cells, and keratinocytes as
well as in the HaCaT cell line. An ubiquitous cationic
amino acid transporter-1 mRNA expression was found
in all cells, whereas constitutive cationic amino acid
transporter-2 mRNA expression occurs in resident
keratinocytes and dermal endothelial cells only. De novo
induction of cationic amino acid transporter-2 and
inducible nitric oxide synthase by proin£ammatory cy-
tokines was seen in ¢broblasts and HaCaT. Competitive
inhibition of the cationic amino acid transporter-
mediated L-arginine transport by culturing primary
human keratinocytes in the presence of increased L-
lysine concentration led to decreased inducible nitric
oxide synthase and arginase activities with a concomi-
tant signi¢cant decrease in keratinocyte proliferation.
In summary, our results demonstrate that human
keratinocytes constitutively express cationic amino acid
transporters 1 and 2 and that cationic amino acid trans-
porter mediated L-arginine in£ux, is essential for both
inducible nitric oxide synthase and arginase enzyme
activities, which in turn modulate proliferation and
di¡erentiation of human epidermal skin cells. Key
words: L-arginine/nitric oxide/iNOS. J Invest Dermatol 120:
1016 ^1022, 2003
T
he cationic amino acid L-arginine is the common
physiologic substrate of nitric oxide synthases
(NOS) and arginases (Mori and Gotoh, 2000). As a
semi-essential amino acid, regulated uptake of L-
arginine from the extracellular space is necessary for
most cell types. The activities of L-arginine metabolizing en-
zymes are dependent on the expression and activity of the catio-
nic amino acid transporters (CAT), mediating the L-arginine
in£ux into the cell (Nicholson et al, 2001). The CAT family con-
sists of four distinct members that di¡er in cellular expression and
transporting properties (Closs and Mann, 1999). Mammalian cells
constitutively express CAT-1, whereas de novo expression of CAT-2,
an inducible isoform, is observed in many di¡erent cell types
during in£ammatory challenges (Kawahara et al, 2001); the
notable exceptions are hepatocytes and muscle cells, which
show a constitutive expression of CAT-2A in the absence of
in£ammatory stimuli. iNOS-derived NO produced by keratino-
cytes is an important signal molecule for regulating gene expres-
sion, wound healing, and keratinocyte proliferation in skin
(Krischel et al, 1998; Frank et al, 1999, 2000). Whereas uptake of
extracellular L-arginine appears not to be required for endothelial
NO synthesis mediated by the constitutively expressed NOS in
human endothelial cells (Closs et al, 2000), uptake of extracellular
arginine is an absolute requirement for high-output NO syn-
thesis, via iNOS, in many di¡erent cell types (Bogle et al, 1992),
especially when concurring L-arginine metabolizing enzymes
are coexpressed. Arginase catalyzes the conversion of arginine to
urea and ornithine, exists as two isoforms: (i) a cytosolic induci-
ble type (arginase-1), and (ii) a mitochondrial type (arginase-2).
Arginase-1 activity is known to increase cell proliferation in
smooth muscle cells (Wei et al, 2001) and also to regulate NO
production (Mori and Gotoh, 2000). Little is known, however,
about arginine transport in human skin and how arginine is sup-
plied to activated keratinocytes where NO and urea are gener-
ated. To investigate this question, we analyzed the expression
pattern of CAT isoforms in human skin biopsies as well as in cell
cultures of primary human skin cells, i.e., ¢broblasts, dermal
endothelial cells, and in the cell line HaCaT. This study demon-
strates the expression of CAT-1 and CAT-2 in human skin. In
addition, we show that the transporters are both functional and
also that they are essential for iNOS and arginase activities, both
regulating cell growth and di¡erentiation as well as various other
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functions. These data substantiate the key role for CAT-mediated
arginine transport in the co-ordinated regulation of iNOS and
arginase activities in human keratinocytes.
MATERIALS AND METHODS
Materials All chemicals were purchased from Sigma (Deisenhofen,
Germany), except when stated otherwise.
Isolation of human keratinocytes and skin biopsies Primary
epidermal keratinocytes were prepared from reduction of mammaplasty
specimens as described previously (Suschek et al, 2001) (Department of
Plastic Surgery, Florence Nightingale Hospital, Dˇsseldorf, Germany).
Cells were cultured under standard cell culture conditions in KGM-2
medium (BioWhittaker Europe, Taufkirchen, Germany). Skin biopsies
were taken from three healthy volunteers and were £ash frozen in liquid
nitrogen and used for reverse transcriptase^polymerase chain reaction
(reverse transcriptase^PCR). All studies were conducted with the
approval of the authors institutional board.
Cell culture All cells were maintained in 60 mm culture dishes.
Keratinocytes were cultured in KBM medium (BioWhittaker Europe)
supplemented with Bovine Pituatary Extract (BPE), human epidermal
growth factor, insulin, hydrocortisone, transferrin, epinephrine, penicillin,
and streptavidin. For iNOS induction, primary keratinocytes were always
cultured in the absence of hydrocortisone. HaCaT and ¢broblasts were
cultured in RPMI 1640 supplemented with 10% fetal bovine serum,
100 mg penicillin per ml, 100 mg streptomycin per ml, nonessential amino
acids, glutamax, and Na-pyruvate (Gibco, Eggenstein, Germany). Dermal
epidermal cells (EC) (PromoCell, Heidelberg, Germany). were cultivated
in endothelial cell growth medium (PromoCell) at 371C under a
humidi¢ed 5% CO2 atmosphere. Media were changed every second day,
and cells were passaged by trypsinization with PBS containing 0.25%
trypsin. Activation of skin biopsies, primary keratinocytes, HaCaT, dermal
EC, and ¢broblasts was achieved with 1000 units each of interleukin-1b,
tumor necrosis factor-a, and interferon-g (Strahtmann, Hanover, Germany).
Cells were incubated for 24 or 48 h. L-N(5)-(1-iminoethyl)ornithine (NIO,
Alexis, Grˇnberg, Germany) was prepared as 10 mM stock solution and
used at a ¢nal concentration of 250 mM in cell culture experiments.
Amino acid supplementation was achieved with 20 mM L-lysine or
L-ornithine or L-arginine singly applied, or in combination as indicated.
RNA Isolation and reverse transcriptase^PCR Total RNA was
isolated using the RNeasy-KIT (Qiagen, Hilden, Germany) following the
manufacturer’s recommendations. The RNA from each probe was
dissolved in 30 ml of RNAse-free water and stored at 701C. First strand
cDNA synthesis was performed in a 20 ml volume using 0.1 mg per ml total
RNA, reverse transcriptase, oligo d(T)15 primer, and deoxyribonucleoside
triphosphate. Five microliters of the resulting cDNA sample were used for
PCR ampli¢cations in a volume of 50 ml containing 5 ml of 10PCR
pu¡er, 1 ml of 10 mM deoxyribonucleoside triphosphate, 1 ml of each
primer 20 pM, and 1 U of Taq polymerase (Qiagen). Primer and PCR
conditions are listed in Table I. Prior to PCR analysis, we routinely
determined the relative amount of the respective speci¢c ampli¢cation
product at di¡erent PCR cycles and thus ensured that ampli¢cation
conditions were always within the linear phase. In some experiments
aliquots of iNOS products were pooled with the GAPDH product and
both were subjected to electrophoresis on 1.8% agarose gels. Bands were
visualized by ethidium bromide staining. Densitometric analysis of the
visualized ampli¢cation products was performed by using the KODAK
1D software (KODAK, Stuttgart, Germany). For all reactions coampli¢ed
cDNA preparations from activated or resident HepG2 cells were used as
positive controls. For negative controls the same RNA preparations were
used with the omission of the reverse transcriptase step.
Sequencing of PCR fragments PCR bands were eluted from the
agarose gel and the DNA extracted with QIAEX II (Qiagen) according
to the manufacturer’s recommendation. One hundred nanograms of
puri¢ed DNA were used for sequence reactions with the same primer
pairs as used for the PCR. Sequencing was performed at the Biological-
Medical Research Center (BMFZ) of the Heinrich-Heine University,
Dˇsseldorf, Germany. The sequence obtained was compared with the
GenBank sequences with the accession numbers mentioned inTable I.
Determination of growth rates and viability of cell cultures Cell
growth was determined at di¡erent times by Neutral Red staining. Cells
were incubated for 60 min with Neutral Red (1 : 100 dilution of a 3%
solution), washed twice with PBS, dried completely, and lyzed with
isopropanol containing 0.5% of 1 M HCl. Extinctions of the supernatants
were then measured at 530 nm.
Determination of arginase activity Cellular arginase activity was
determined indirectly by measuring the concentration of urea in culture
supernatants using an urea detection kit (Urea Nitrogen Assay; Sigma).
Brie£y, urea is hydrolyzed by urease and the reaction of ammonia with
alkaline hypochlorite and phenol in the presence of sodium nitroprusside
forms indophenol. The concentration of urea is directly proportional to
the absorbance of indophenol, which is measured spectrophotometrically
at 540 nm of wavelength in a microplate reader (Titertek Multiscan Plus,
Flow Laboratories, Heidelberg, Germany).The assay was modi¢ed to allow
for measurement of 20 ml culture supernatants.
Determination of NOS activity iNOS activity was assayed indirectly
by measuring nitrite accumulation in 100 ml culture supernatants using
the diazotization reaction (Wood et al, 1990). Nitrite concentrations
were calculated by comparison with the absorbance of standard solutions
of NaNO2 prepared in cell culture medium.
Immunohistochemical analysis Immunohistochemistry was per-
formed exactly as described previously (Bruch-Gerharz et al, 1996). iNOS
protein was detected by using a mouse monoclonal antibody to
macrophage iNOS (Santa Cruz, Santa Cruz, CA). For negative controls,
the ¢rst antibody was replaced by an irrelevant isotype-matched control.
Arginase-1 protein expression was examined using an anti-arginase-1
anti-serum that cross-reacts with the human enzyme. The polyclonal
antibody for arginase-1 was raised in rabbits immunized with a synthetic
Table I. GenBank accession no. and sequences of primers used
Product/GenBank accession no. Sequence Fragment size
Human GAPDH M17851 Sense 50 -ATGCCCGATGGCACCATCAGA-30 (bases 153^175)
Anti-sense 50 -TCTCCAGGCCCATCCTCCTGC-30 (bases 548^568)
Cycle protocol 19 (30 s 941C, 30 s 581C, 60 s 721C)þ 5 min 721C 416 bp
Human iNOS D29675 Sense 50 -ATGCCCGATGGCACCATCAGA-30 (bases 1020^1040)
Anti-sense 50 -TCTCCAGGCCCATCCTCCTGC-30 (bases 1393^1413)
Cycle protocol 40 (30 s 941C, 60 s 601C, 60 s 721C)þ 5 min 721C 394 bp
Human CAT-1 AF078107 Sense 50 -CCAACGTCAATGATAGGACC-30 (bases 1247^1266)
Anti-sense 50 -CTGGTCCAGCTGCATCATGA-30 (bases 1850^1869)
Cycle protocol 28 (30 s 941C, 60 s 601C, 60 s 721C)þ 5 min 721C 622 bp
Human CAT-2 D29990 Sense 50 -AGCCTGGCTTATCTTACGAC-30 (bases 1293^1323)
Anti-sense 50 -AATCTGACCCAAGTGTCTGC-30 (bases 1741^1760)
Cycle protocol 32 (30 s 941C, 60 s 601C, 60 s 721C)þ 5 min 721C 467 bp
Human arginase-1M14502 Sense 50 -CTTAAAGAACAAGAGTGTGATG-30 (bases 174^195)
Anti-sense 50 -TTCTTCCTAGTAGATAGCTGAG-30 (bases 702^723)
Cycle protocol Cell culture: 34 (30 s 941C, 60 s 501C; 60 s 721C)þ 5 min 721C
Skin specimen: 28 (30 s 941C, 60 s 501C; 60 s 721C)þ 5 min 721C 549 bp
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peptide (EGN HKP ETDYLK PPK) representing amino acids 348^362 of
rat arginase-1.
Statistical analysis Data are given as mean7SD. Values were
calculated using analysis with Student’s t test (two tailed for independent
samples).
RESULTS
CAT-1 and CAT-2 are expressed in human skin Skin
biopsies from three healthy volunteers were analyzed for CAT-1
and CAT-2 mRNA expression. As shown in Fig 1 both members
of cationic amino acid transporters are expressed in all three skin
samples.
Next, we studied the di¡erential expression of the CAT
members in the three main skin cell populations and the impact
of proin£ammatory cytokines on their expression levels.
Expression patterns of CAT were analyzed in primary isolated
keratinocytes, dermal endothelial cells, and ¢broblasts as well as
in the keratinocyte-derived cell line HaCaTall cells of human
origin. As shown in Fig 2, resident expression of CAT-1mRNA
was found in all skin cells, and only in HaCaT a signi¢cant
increase during cytokine challenge (interleukin-1b, tumor
necrosis factor-a, and interferon-g 1000 U each) was seen. The
highest level of CAT-1 mRNA expression is found in HaCaT
compared the other investigated skin cells. With nonactivated
cells, only primary keratinocytes and dermal EC constitutively
express CAT-2 mRNA with an increase by a factor of 4.070.4
in keratinocytes and 4.170.3 in dermal EC during cytokine
challenge. Neither resident ¢broblasts nor HaCaT cells express
CAT-2, but after cytokine challenge de novo CAT-2 expression
after 24 h is seen in both cell types. Cytokine challenge of
keratinocytes, dermal endothelial cells, and ¢broblasts also leads
to de novo induction of iNOS mRNA in accordance to earlier
observations. We have sequenced the PCR fragments from
CAT-1- and CAT-2-speci¢c ampli¢cations, and the sequence
alignment with the respective sequence in databases (Table I)
gives 100% identity. As iNOS-derived NO synthesis has been
linked recently to modulation of gene expression, we also tested
whether cytokine-induced CAT-2 expression or overexpression is
under the control of NO by culturing the activated cells in the
presence of the NOS inhibitor L-NIO (250 mM). The unchanged
expression levels in all cells demonstrate that CAT expression is
independent of NO synthesis.
Kinetics of CAT-2 mRNA expression di¡er between HaCaT
and primary keratinocytes Next we examined the time
course of cytokine-mediated changes in CAT-2-speci¢c mRNA
levels (Fig 3) in HaCaT (Fig 3A) and primary keratinocytes
(Fig 3B). In HaCaT cells CAT-2 mRNA induction was seen as
early as 1 h after cytokine addition with a maximum at 2^8 h
and a slow decrease thereafter, despite the continued presence of
cytokines. Half maximal expression was seen at 24 and 48 h.
Primary keratinocytes di¡er signi¢cantly, as they constitutively
express CAT-2 mRNA, and a cytokine-induced increase begins
after 2 h and is maximal at 24 h with a subsequent minor decrease
at 48 h. In HaCaT and in primary keratinocytes we ¢nd an
identical time course of induction of iNOS expression: after
4^8 h a ¢rst signal is seen and maximal expression is found after
24 h, which slowly decreases after 48 h (data not shown). This
demonstrates that expressional modulation of iNOS di¡ers from
the modulation of CAT-2 expression.
Competing for L-arginine import leads to decreased iNOS
and arginase activity in keratinocytes To determine the
functionality of CAT expression, we analyzed iNOS and argi-
nase enzyme activities, as both depend on L-arginine transport
availability. We ¢nd arginase-1 mRNA (Fig 4) and protein
(Fig 5) constitutively expressed in primary keratinocytes.
Activation by proin£ammatory cytokines leads to a signi¢cant
decrease of arginase-1 mRNA, which is paralleled by de novo
induction of iNOS mRNA and iNOS protein, indicating the
known reverse regulation of arginase-1 and iNOS expression.
During the ¢rst 24 h of incubation neither arginase-1 protein
level (Fig 5) nor its activity changed signi¢cantly; however, 96 h
after cytokine challenge arginase activity drops to 6475% of the
resident, nonactivated cells (Fig 4B). The enzyme activity of
iNOS, was measured as nitrite concentrations in culture super-
natants (Fig 6A). Activation of keratinocytes leads to a signi¢-
cant increase in nitrite concentrations, which is completely
blocked by the addition of NIO (250 mM). Increasing the
medium concentration of L-lysine or of a combination of
L-lysine and L-ornithine, thereby competing for arginine
transport, results in signi¢cantly reduced nitrite accumulation at
48 h to 5674% and 2175%, respectively, whereas L-ornithine
alone does not a¡ect iNOS activity. In the same cell culture
supernatants, we analyzed arginase activity by measuring the
urea accumulation in culture supernatants (Fig 6B). In
accordance with the above described constitutive arginase
expression, we measure relatively high levels of urea in
keratinocyte culture supernatants, which was unchanged by
cytokine activation, during the ¢rst 24 h. Competing
for arginine transport reduces arginase activity about 3075%
(L-lysine) or 9074% (L-ornithine) as compared with resident
cells. A combination of both amino acids completely inhibits
arginase activity. These data demonstrate that CAT-mediated
L-arginine transport limits both iNOS-derived NO production
as well as arginase activity in human keratinocytes.
The impact of CAT expression on human keratinocyte
proliferation Finally, we studied the impact of CAT-mediated
L-arginine transport on cell growth in resident human
keratinocytes (Fig 7). An inhibition of arginase activity by
L-lysine signi¢cantly slows down cell proliferation to about
40% of sham-treated controls with some loss of cells at the
end of the culture period. In contrast, supplementation with
L-arginine does not lead to a proliferation slow-down.
The ornithine decarboxylase inhibitor Di£uor-methyl-orui£eme
(DFMO) leads to a slight proliferation decrease during the ¢rst
48 h, with a subsequent complete arrest of cell growth with
neither cell death nor detachment occurring. L-lysine combined
with L-ornithine results in cell detachment in a signi¢cant
portion of live cells starting at 48 h of incubation, with no
signals of increased apoptosis or necrosis.
GAPDH
CAT-1
CAT-2
500bp
500bp
500bp
Figure1. Both, CAT-1 and CAT-2 mRNA are constitutively ex-
pressed in normal human skin specimens. RNAwas extracted from
three normal skin samples from di¡erent donors and reversly transcribed
and ampli¢ed by PCRwith primers speci¢c for CAT-1 (622 bp), CAT-2
(457 bp), and GAPDH (416 bp). All three gene products were detected in
skin samples from three di¡erent donors.
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DISCUSSION
It is currently well established that L-arginine transport is in-
volved in regulating iNOS and arginase activities in di¡erent tis-
sues (Irie et al, 1997; Louis et al, 1999). Regulation of NOS activity
is a major component in skin homeostasis, caused by the impact
of NO on proliferation, di¡erentiation, wound healing, and gene
expression in human skin (Bruch-Gerharz et al, 1998). Therefore,
we performed ex vivo and in vitro experiments using skin biopsies
as well as cultured primary human skin cells and cell lines to ob-
tain further information about L-arginine transport in human
skin cells and its in£uence on NO formation and arginase acti-
vity. We now demonstrate, that gene transcripts of CAT-1 and
CAT-2 are constitutively expressed in biopsies of normal human
skin. This ¢nding was unexpected, because most mammalian
cells display a de novo expression of CAT-2 during in£ammatory
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Figure 3. Di¡erent kinetics of CAT-2 mRNA expression are found
in human keratinocytes and HaCaT cells during proin£ammatory
cytokine challenge. The time course of CAT-2 mRNA expression in
HaCaT (A) and primary keratinocytes (B) after cytokine challenge shows
prominent di¡erences between the primary cell and the immortalized line.
Cells were treated with a cytokine cocktail (as in Fig 2) for the time
periods indicated. The relation of speci¢c ampli¢cation product intensities
relative to the housekeeping gene is shown above the representative gels.
Values are the mean7SD of three individual experiments.
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Figure 4. Activated human keratinocytes coexpress arginase-1 and
iNOS mRNA. (A) Activation of primary keratinocytes as in Fig 2 leads
to de novo formation of iNOS mRNA within 24 h and a signi¢cant de-
crease of arginase mRNA to 45712% as compared with nonactivated
cells. (B) Arginase activity does not change during the ¢rst 24 h after cyto-
kine challenge, but a signi¢cant reduction of 3276% is found after 96 h of
activation.
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Figure 5. Immunocytochemistry demonstrates iNOS and arginase-
1 expression at the protein level. Cultured primary keratinocytes with
(activated) or without (resident) cytokine challenge as in Fig 2 were stained
for iNOS and arginase-1 protein expression. In three independent immu-
nocytochemical staining experiments we ¢nd a strong signal for arginase-1
expression in resident keratinocytes (B) as well as in activated cells (D)
without signi¢cant di¡erences in expression levels, whereas the iNOS-spe-
ci¢c signal was found in activated keratinocytes only (C), but not in resi-
dent cells (A). Isotype-matched control antibodies (E,F) were always
negative. Scale bar: 100 mM. Original magni¢cation:  220.
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conditions only (Closs et al, 1997), with the exception of hepato-
cytes, a ¢nding that led researchers to the name of ‘‘liver-type
CAT’’ for the CAT-2A isoform. In the next step we investigated
the distribution of cellular CATexpression in the three major cell
types from human skin. Our results demonstrate a constitutive
expression of CAT-1 mRNA in all resident cells, which is af-
fected by cytokines in the HaCaTcell line only.This was an inter-
esting ¢nding, because a wide range of cell types express CAT-1,
and here we show for the ¢rst time a cytokine-dependent up-
regulation, although these cells already express the highest level of
CAT-1mRNA in the resident state. Surprisingly, CAT-2 mRNA
was found to be constitutively expressed in resident keratinocytes
and dermal endothelial cells. It is noteworthy that these cells also
constitutively express arginase-1 in their resident state. Again, the
same expression pattern of L-arginine metabolizing and trans-
porting molecules is found in hepatocytes (Tabuchi et al, 2000),
thus a constitutive expression of arginase-1 together with CAT-2
might be characteristic for many epithelial cells. Cytokine chal-
lenge results in CAT-2 mRNA upregulation in primary kerati-
nocytes and dermal EC, whereas in HaCaT and ¢broblasts de
novo synthesis of CAT-2 mRNA was observed. CAT-2 mRNA
expression was paralleled by coinduction of iNOS mRNA in all
skin cells, indicating a nuclear factor-kB-mediated pathway
(Hammermann et al, 2000) that ensures a high substrate supply
for iNOS and arginases in skin cells. The slightly faster CAT-2
expression as compared with the iNOS induction kinetics (data
not shown), might well represent an important timing for proper
iNOS function. In resident keratinocytes neither iNOS mRNA
nor iNOS protein was detectable, but activation with proin£am-
matory cytokines led to the formation of iNOS mRNA and pro-
tein within 24 h of culture in accordance with earlier reports. In
contrast, upon cytokine addition constitutively expressed argi-
nase-1 mRNA decreases to 45712% relative to resident cells.
The expressional levels of arginase-1 protein, however, appear
unchanged within the ¢rst 24 h as monitored by enzyme activity;
this is most probably due to its long half-life of 4 d (Schimke,
1979), as indeed a signi¢cant reduction of 3276% of the basal
arginase activity was found after 96 h of activation. To elucidate
the impact of CAT-mediated L-arginine transport in skin cells,
we investigated the events following competition for L-arginine
transport by excess L-lysine and/or L-ornithine on the enzyme
activities of arginase and iNOS in human keratinocytes. A sur-
prising notion comes from comparing primary keratinocytes
with the cell line HaCaT, showing major di¡erences in CAT and
arginase expressions. Thus, this cell line appears not to represent
events in primary keratinocytes when studying arginine metabo-
lism. Supplementation with L-lysine alone or in combination
with L-ornithine results in decreased iNOS activity to 5674%
or 2175% relative to control activated keratinocytes. This indi-
cates that CAT-mediated uptake of L-arginine is an absolute
requirement for proper iNOS function. L-ornithine supple-
mentation does not inhibit iNOS activity, suggesting that kera-
tinocytes are capable of ornithine-derived arginine synthesis
within the urea cycle and thus keep iNOS activity maximal. In
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Figure 6. Competitive inhibition of L-arginine transport leads to
reduced enzyme activities of iNOS and arginase in keratinocytes.
(A) In supernatants of resident keratinocyte cultures (R) not expressing
iNOS background levels only of nitrite were detected, whereas after 48 h
of cytokine challenge (A) a signi¢cant increase in nitrite concentrations
(npo0.001 as compared with resident cells) demonstrates iNOS activity.
Inhibiting iNOS with NIO decreases nitrite production to background
levels. Supplementation with L-lysine or a combination of L-lysine and
L-ornithine signi¢cantly decreases iNOS activity, whereas L-ornithine
alone does not a¡ect nitrite accumulation. (B) Arginase activity was exam-
ined by determining urea concentrations in the same culture supernatants.
Resident cells produce relatively high amounts of urea. Supplementation
with L-lysine (20 mM) leads to a signi¢cantly (npo0.005) reduced arginase
activity of about 5674% relative to sham-treated cells. Supplementation
with L-ornithine (20 mM) or a combination of L-lysine and L-ornithine
(20 mM each) reduces arginase activity by more than 90% (nnpo0001).
Values are the mean7SD from three individual experiments.
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Figure 7. Competition for L-arginine transport slows proliferation
in primary human keratinocytes. Keratinocytes were cultured in the
continuous presence of additional amino acid supplementations (’¼
L-glycine [20 mM]; ¼L-lysine [20 mM]; E¼L-lysineþL-ornithine
[20 mM each]; *¼L-arginine [20 mM]; &¼DFMO [5 mM]) for up to
5 d. Inhibition of CATmediated L-arginine transport by L-lysine or inhi-
bition of polyamine synthesis by DFMO, a well known inhibitor of
ornithine decarboxylase, signi¢cantly slows proliferation (npo0.01 as
compared with glycine supplemented cells), whereas a combination of
L-lysine and L-ornithine slows proliferation for the ¢rst 2 d and then
results in a loss of cells. Addition of 20 mM of L-arginine does not a¡ect
proliferation.Values are the mean7SD from three individual experiments.
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contrast, arginase activity falls to 10% of its activity in the pre-
sence of L-lysine applied singly or in combination with L-or-
nithine. This e¡ect is best explained as enzyme product
inhibition mediated by L-ornithine in combination with e¡ective
transport competition of L-lysine and subsequent L-arginine de-
privation. Recently, L-arginine transport and arginase activity
were reported to be rate limiting for endothelial cell proliferation
(Ignarro et al, 2001;Wei et al, 2001; Li et al, 2002). Here we demon-
strate for the ¢rst time, that this also applies for keratinocyte pro-
liferation. Inhibition of L-arginine transport in resident primary
keratinocytes signi¢cantly decreases growth rates and is followed
by cell death after 48 h. In contrast, inhibition of the ornithine
decarboxylase by addition of DFMO inhibits cell proliferation
leading to an arrest without inducing cell death probably due to
restricted polyamine availability. In conclusion, we here demon-
strate that L-arginine uptake via the CAT system is an essential
modulator of keratinocyte proliferation as it limits iNOS activity;
however, in addition, e¡ects independent of high output NO
formation are also found, as our experiments were performed
with resident keratinocytes, where iNOS is not expressed.
Taken together, our results demonstrate, that CAT expression
in human skin is an important player in modulating iNOS and
arginase activities by regulating the availability of their common
substrate L-arginine. Our results demonstrate, that CAT gene
expression is an absolute requirement for L-arginine uptake and
iNOS and arginase activities in human skin cells. We have also
shown that this represents a important component in regulating
keratinocyte proliferation. In view of the earlier ¢nding of iNOS
expression in keratinocytes during proin£ammatory skin reac-
tions, such as psoriasis, or ultraviolet challenge or wound healing
an expression pro¢le of both CATas well as arginase genes might
help to understand the local conditions in these di¡erent in£am-
matory reactions.
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